Úsek pro vědu a výzkum

What are the results of this type of treatment for patients?

It is difficult to speak in general terms. Every diagnosis is different and every patient comes in a different condition. However, in 2012 an analysis was made for transplants performed in 1986–2010 and the results are as follows:

Acute myeloid leukemia: The five-year survival rate is approximately 50 percent; about 40 percent of patients survive more than ten years.

Chronic myeloid leukemia: The long-term survival is around 70 percent. Patients transplanted after the year 2000 have an 85–90 percent probability of ten-year survival, while the survival of patients transplanted earlier is around 60 percent.

Myelodysplastic syndrome: Patients transplanted at a less advanced stage of disease have approximately 70 percent probability of ten-year survival, while patients transplanted at an advanced stage have around 30 percent probability.

Acute lymphoblastic leukemia: Transplanted patients have a 50 percent probability of long-term survival.